Leiv Lea
CIK: 0000939012
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRVS
Corvus Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
About LEA LEIV
LEA LEIV (SEC CIK 0000939012) files insider reports with the SEC as Chief Financial Officer of Corvus Pharmaceuticals, Inc. (CRVS).
Signal8 holds 2 ownership filings by LEA LEIV, all Form 4s, filed between Dec 23, 2024 and Dec 8, 2025. Those filings report 2 transactions, from Dec 20, 2024 to Dec 4, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on LEA LEIV's filings is in BURLINGAME, CA.
Recent filings by LEA LEIV
Other insiders filing for Corvus Pharmaceuticals, Inc. (CRVS)
- Moore David Scott, Director
- CLARK IAN T, Director
- Grais Linda, Director
- Thompson Peter A., Director
- van den Broek Richard, Director
- MILLER RICHARD A MD, President and CEO